New insights into the roles of peroxiredoxins in cancer.

Abstract

Oxidative stress is one of the hallmarks of cancer. Tumorigenesis and progression are accompanied by elevated reactive oxygen species (ROS) levels and adaptive elevation of antioxidant expression levels. Peroxiredoxins (PRDXs) are among the most important antioxidants and are widely distributed in a variety of cancers. PRDXs are involved in the regulation of a variety of tumor cell phenotypes, such as invasion, migration, epithelial-mesenchymal transition (EMT) and stemness. PRDXs are also associated with tumor cell resistance to cell death, such as apoptosis and ferroptosis. In addition, PRDXs are involved in the transduction of hypoxic signals in the TME and in the regulation of the function of other cellular components of the TME, such as cancer-associated fibroblasts (CAFs), natural killer (NK) cells and macrophages. This implies that PRDXs are promising targets for cancer treatment. Of course, further studies are needed to realize the clinical application of targeting PRDXs. In this review, we highlight the role of PRDXs in cancer, summarizing the basic features of PRDXs, their association with tumorigenesis, their expression and function in cancer, and their relationship with cancer therapeutic resistance.

• Authors: Yan Liu, Pu Wang, Weina Hu, Da Chen
• Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 164 Pg. 114896 (Aug 2023) ISSN: 1950-6007 [Electronic] France
• PMID: 37210897 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Chemical References

• Peroxiredoxins
• Reactive Oxygen Species
• Antioxidants

Topics

• Humans
• Peroxiredoxins (metabolism)
• Neoplasms
• Oxidative Stress
• Reactive Oxygen Species (metabolism)
• Antioxidants (metabolism)
• Carcinogenesis
• Epithelial-Mesenchymal Transition